Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lung Cancer Diagnosis
- Sponsor
- NYU Langone Health
- Enrollment
- 1800
- Locations
- 5
- Primary Endpoint
- Fraction of patients engaging in at least one telehealth visit
- Status
- Recruiting
- Last Updated
- 7 months ago
Overview
Brief Summary
The objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across personal characteristics.
Detailed Description
Study staff will use the Veterans Health Information Systems and Technology Architecture (VistA), the VA health information technology system, to identify eligible patients at VA sites based on listed inclusion and exclusion criteria. Patient records will be observed of Veterans with a new cancer diagnosis of the lung, prostate, breast, or colon and a telehealth visit utilizing the VA National TeleOncology Service (NTO).
Investigators
Eligibility Criteria
Inclusion Criteria
- •Aged 18 years or older
- •Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit
- •Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location.
- •VAMC Providers and Staff Inclusion Criteria:
- •Provider or staff member at one of the VAMC locations including physicians, nurse practitioners, physicians' assistants, and nurses caring for Veterans
- •Providers or staff members having helped provide care for at least 5 Veterans with cancer in the previous 6 months at a VAMC location
Exclusion Criteria
- •Veterans who have not seen any providers in the VA within the past year
- •Patients previously diagnosed with lung, prostate, breast, or colon cancer
- •Pregnant patients
- •VAMC Providers and Staff Exclusion Criteria:
- •1\. Providers or staff members who do not help treat Veterans with specified cancers in oncology at the VA
Outcomes
Primary Outcomes
Fraction of patients engaging in at least one telehealth visit
Time Frame: Post-NTO implementation (up to 3 months)
Telehealth utilization among Veterans with cancer will be measured by fraction of patients engaging in at least one telehealth visit.
Number of raw telehealth visits
Time Frame: Post-NTO implementation (up to 3 months)
Telehealth utilization among Veterans with cancer will be measured through raw telehealth visit counts.
Secondary Outcomes
- Average total cost for cancer diagnosis, treatment and downstream HealthCare utilization(Post-NTO implementation (up to 3 months))
- Time of consultation to time of first treatment(Pre-implementation, post-NTO implementation (up to 3 months))
- Change in provider level Quality Oncology Practice Initiative (QOPI) score(Pre-implementation, post-NTO implementation (up to 3 months))
- Time of consultation to time of first appointment(Pre-implementation, post-NTO implementation (up to 3 months))